Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Kidney Neoplasms × Prednisone × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 27 Lymphoma, Large B-Cell, Diffuse 15 Lymphoma 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia 6 Burkitt Lymphoma 6 Neoplasms 5 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Follicular 5 Lymphoma, B-Cell 5 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Lymphoma, T-Cell 3 Pain 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphatic Diseases 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Hematologic Diseases 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Prostate Cancer Metastatic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms, Plasma Cell 1

Interventions

Cyclophosphamide 9 fludarabine 8 Interleukin-2 7 aldesleukin 6 Everolimus 6 Bevacizumab 6 Sunitinib 5 Sorafenib 5 fludarabine phosphate 4 Nivolumab 4 Filgrastim 4 pembrolizumab 3 Stem Cell Transplantation 3 Radiotherapy, Intensity-Modulated 3 Melphalan 3 Granulocyte Colony-Stimulating Factor 3 Gene Expression Profiling 3 peginterferon alfa-2b 2 cabozantinib 2 atezolizumab 2 Thiotepa 2 Reverse Transcriptase Polymerase Chain Reaction 2 Polymerase Chain Reaction 2 Peripheral Blood Stem Cell Transplantation 2 Mesna 2 Immunoenzyme Techniques 2 Flow Cytometry 2 Cryosurgery 2 Busulfan 2 Bone Marrow Transplantation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02479490 2018-01-16

PREV

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Terminated

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡